Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,631,771
-$228,181 QoQ
Shares Held
14,300
-9.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,853
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $29,476,537 across 10 Drug Manufacturers - General names. JNJ ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,332 | $13,591,941 | |
| 2 | ABBV |
AbbVie Inc.
|
16,225 | $4,082,859 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
14,300 | $3,631,771 | |
| 4 | NVS |
Novartis AG
|
12,291 | $1,926,245 | |
| 5 | PFE |
Pfizer Inc
|
69,231 | $1,667,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,133 | $1,559,090 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,457 | $948,252 | |
| 8 | AMGN |
Amgen Inc
|
2,399 | $868,725 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,631,771 | 14,300 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,859,952 | 15,791 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,288,228 | 15,889 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,937,794 | 15,844 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,632,188 | 17,232 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,786,443 | 16,802 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,193,885 | 15,170 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,395,732 | 14,783 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,210,085 | 15,121 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,264,806 | 14,317 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,134,015 | 13,615 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,033,939 | 13,059 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,982,267 | 11,976 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,961,525 | 12,655 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,279,844 | 12,906 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,091,988 | 12,806 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,263,074 | 12,749 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,235,047 | 12,611 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,129,308 | 12,447 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,992,587 | 12,338 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,009,333 | 12,197 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,156,436 | 13,121 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,113,613 | 13,430 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,939,608 | 13,028 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,996,524 | 14,197 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,822,444 | 13,898 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||